Susceptibility of 2,252 Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9 Antimicrobials in a Tertiary Greek Hospital

Publisher： Karger

E-ISSN： 1421-9794|60|5-6|334-341

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.5-6, 2015-0, pp. : 334-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of Fluoroquinolone and Carbapenem Susceptibilities in Clinical Isolates of Levofloxacin-Resistant Pseudomonas aeruginosa

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Release of Exotoxin A, Peptidoglycan and Endotoxin after Exposure of Clinical Pseudomonas aeruginosa Isolates to Carbapenems in vitro

By  

Chemotherapy, Vol. 51, Iss. 6, 2005-11 ,pp. : 324-331

Karger

Access to resources Recommend Favorite

In vitro Activity of Ceftazidime, Cefepime and Imipenem on 1,005 Pseudomonas aeruginosa Clinical Isolates either Susceptible or Resistant to Beta-Lactams

By  

Chemotherapy, Vol. 46, Iss. 4, 2000-06 ,pp. : 229-234

Karger

Access to resources Recommend Favorite

First Detection of OXA-10 Extended-Spectrum Beta-Lactamases and the Occurrence of mexR and nfxB in Clinical Isolates of Pseudomonas aeruginosa from Nigeria

By  

Chemotherapy, Vol. 61, Iss. 2, 2015-0 ,pp. : 87-92

Karger

Access to resources Recommend Favorite

Surveillance of Antimicrobial Susceptibility among Bacterial Isolates from Intensive Care Unit Patients of a Tertiary-Care University Hospital in Iran: 2006–2009

By  

Chemotherapy, Vol. 56, Iss. 6, 2010-11 ,pp. : 478-484

Karger

Access to resources Recommend Favorite